Soni Medicare [SML] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison
Soni Medicare
BSE
Loading...
Indraprastha Medical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Soni Medicare wins in 6 metrics, Indraprastha Medical wins in 12 metrics, with 0 ties. Indraprastha Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Soni Medicare | Indraprastha Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 103.13 | 26.75 | Indraprastha Medical |
| Price-to-Book Ratio | 18.21 | 7.52 | Indraprastha Medical |
| Debt-to-Equity Ratio | 810.21 | 5.49 | Indraprastha Medical |
| PEG Ratio | -1.55 | 1.79 | Soni Medicare |
| EV/EBITDA | 25.63 | 16.33 | Indraprastha Medical |
| Profit Margin (TTM) | 1.24% | 12.21% | Indraprastha Medical |
| Operating Margin (TTM) | -0.54% | 17.25% | Indraprastha Medical |
| EBITDA Margin (TTM) | N/A | 17.25% | N/A |
| Return on Equity | -14.25% | 26.98% | Indraprastha Medical |
| Return on Assets (TTM) | -0.84% | 18.90% | Indraprastha Medical |
| Free Cash Flow (TTM) | $8.76M | $1.20B | Indraprastha Medical |
| Dividend Yield | N/A | 1.13% | N/A |
| 1-Year Return | 215.85% | -1.49% | Soni Medicare |
| Price-to-Sales Ratio (TTM) | 1.27 | 3.26 | Soni Medicare |
| Enterprise Value | $486.72M | $41.34B | Indraprastha Medical |
| EV/Revenue Ratio | 1.55 | 3.01 | Soni Medicare |
| Gross Profit Margin (TTM) | 72.61% | 38.19% | Soni Medicare |
| Revenue per Share (TTM) | $125 | $150 | Indraprastha Medical |
| Earnings per Share (Diluted) | $0.91 | $18.27 | Indraprastha Medical |
| Beta (Stock Volatility) | -0.36 | 0.61 | Soni Medicare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Soni Medicare vs Indraprastha Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Soni Medicare | 2.00% | 10.38% | 71.31% | 84.63% | 186.73% | 185.05% |
| Indraprastha Medical | -1.02% | 3.23% | 1.29% | 11.60% | 44.43% | -12.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Soni Medicare | 215.85% | 221.15% | 169.70% | 509.81% | 509.81% | 509.81% |
| Indraprastha Medical | -1.49% | 591.36% | 839.00% | 689.71% | 949.72% | 867.90% |
News Based Sentiment: Soni Medicare vs Indraprastha Medical
Soni Medicare
News based Sentiment: MIXED
Soni Medicare experienced significant positive momentum with a new all-time high stock price and strong returns, but concerns remain regarding its negative ROE and a slight decline in recent revenue. This creates a mixed investment picture, balancing strong growth with underlying financial challenges.
Indraprastha Medical
News based Sentiment: MIXED
Indraprastha Medical delivered improved profitability in Q1 FY2026, but slower revenue growth and an unclear price target from HDFC Securities create a mixed investment picture. The announcement of a strategic shift and new product line adds an element of potential, but requires further investigation.
Performance & Financial Health Analysis: Soni Medicare vs Indraprastha Medical
| Metric | SML | INDRAMEDCO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹410.23M | ₹44.25B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,031 | 159,391 |
| 90 Day Avg. Volume | 1,199 | 194,344 |
| Last Close | ₹97.63 | ₹471.85 |
| 52 Week Range | ₹29.50 - ₹97.63 | ₹307.25 - ₹572.00 |
| % from 52W High | 0.00% | -17.51% |
| All-Time High | ₹97.63 (Sep 09, 2025) | ₹572.00 (Jan 06, 2025) |
| % from All-Time High | 0.00% | -17.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.05% |
| Quarterly Earnings Growth | 0.03% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.12% |
| Operating Margin (TTM) | -0.01% | 0.17% |
| Return on Equity (TTM) | -0.14% | 0.27% |
| Debt to Equity (MRQ) | 810.21 | 5.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹5.16 | ₹65.04 |
| Cash per Share (MRQ) | ₹4.70 | ₹35.08 |
| Operating Cash Flow (TTM) | ₹-10,088,000 | ₹1.78B |
| Levered Free Cash Flow (TTM) | ₹-1,864,000 | ₹1.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.13% |
| Last 12-Month Dividend | N/A | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Soni Medicare vs Indraprastha Medical
| Metric | SML | INDRAMEDCO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 103.13 | 26.75 |
| Forward P/E | N/A | 195.50 |
| PEG Ratio | -1.55 | 1.79 |
| Price to Sales (TTM) | 1.27 | 3.26 |
| Price to Book (MRQ) | 18.21 | 7.52 |
| Market Capitalization | ||
| Market Capitalization | ₹410.23M | ₹44.25B |
| Enterprise Value | ₹486.72M | ₹41.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.55 | 3.01 |
| Enterprise to EBITDA | 25.63 | 16.33 |
| Risk & Other Metrics | ||
| Beta | -0.36 | 0.61 |
| Book Value per Share (MRQ) | ₹5.16 | ₹65.04 |
Financial Statements Comparison: Soni Medicare vs Indraprastha Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SML | INDRAMEDCO |
|---|---|---|
| Revenue/Sales | ₹72.77M | ₹3.34B |
| Cost of Goods Sold | ₹19.93M | ₹2.13B |
| Gross Profit | ₹52.84M | ₹1.21B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-402,000 | ₹504.10M |
| EBITDA | ₹897,000 | ₹676.70M |
| Pre-Tax Income | ₹-2.94M | ₹552.70M |
| Income Tax | ₹-50,000 | ₹142.60M |
| Net Income (Profit) | ₹-2.91M | ₹410.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SML | INDRAMEDCO |
|---|---|---|
| Cash & Equivalents | ₹20.10M | ₹614.80M |
| Total Current Assets | ₹137.75M | ₹4.31B |
| Total Current Liabilities | ₹103.85M | ₹1.79B |
| Long-Term Debt | ₹94.12M | ₹305.40M |
| Total Shareholders Equity | ₹13.08M | ₹5.97B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹60.31M | ₹3.27B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SML | INDRAMEDCO |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SML | INDRAMEDCO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 2,031 | 159,391 |
| Average Daily Volume (90 Day) | 1,199 | 194,344 |
| Shares Outstanding | 4.26M | 91.67M |
| Float Shares | 705,803 | 41.01M |
| % Held by Insiders | 0.83% | 0.58% |
| % Held by Institutions | 0.00% | 0.03% |
Dividend Analysis & Yield Comparison: Soni Medicare vs Indraprastha Medical
| Metric | SML | INDRAMEDCO |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹4.50 |
| Last 12-Month Dividend Yield | N/A | 1.13% |
| 3-Year Avg Annual Dividend | N/A | ₹3.33 |
| 3-Year Avg Dividend Yield | N/A | 2.17% |
| 3-Year Total Dividends | N/A | ₹10.00 |
| Ex-Dividend Date | N/A | Sep 13, 2024 |